Health ❯ Vaccines ❯ Vaccine Development ❯ FDA Regulations
In a NEJM letter, twelve ex-commissioners say the VAERS-based claim lacks transparent methods, with proposed shifts away from immunobridging likely to slow critical vaccine updates.